January 30, 2019
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
Read More
January 30, 2019
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
Read More
January 30, 2019
Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)
Read More
January 30, 2019
Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)
Read More
January 30, 2019
PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a)
Read More
January 30, 2019
The Effectiveness of Paritaprevir/r – Ombitasvir, ± Dasabuvir, ± Ribavirin in France
Read More
January 30, 2019
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
Read More
January 30, 2019
A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue
Read More
January 30, 2019
Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C
Read More
January 30, 2019
Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
Read More
January 30, 2019
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)
Read More
January 30, 2019
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Read More
Load More
X